SenesTech, Inc., a company listed on The Nasdaq Stock Market, has received an extension from Nasdaq to regain compliance with the minimum bid price requirement. On August 25, 2023, SenesTech was notified by Nasdaq that its common stock had fallen below the $1.00 minimum bid price for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). Initially, the company was given until February 21, 2024, to address this issue. However, on February 26, 2024, Nasdaq granted SenesTech an additional 180 days, until August 19, 2024, to meet the requirement. This decision was based on SenesTech's compliance with all other applicable initial listing standards, except for the bid price, and its intent to cure the deficiency, potentially through a reverse stock split. The company will regain compliance if its stock's closing bid price reaches at least $1.00 for 10 consecutive business days within this period. Failure to demonstrate compliance by the deadline may lead to delisting, although SenesTech would have the right to appeal. The company's future ability to meet the Nasdaq's continued listing requirements remains uncertain.

SenesTech, Inc., a company listed on The Nasdaq Stock Market, has received an extension from Nasdaq to regain compliance with the minimum bid price requirement. On August 25, 2023, SenesTech was notified by Nasdaq that its common stock had fallen below the $1.00 minimum bid price for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). Initially, the company was given until February 21, 2024, to address this issue. However, on February 26, 2024, Nasdaq granted SenesTech an additional 180 days, until August 19, 2024, to meet the requirement. This decision was based on SenesTech's compliance with all other applicable initial listing standards, except for the bid price, and its intent to cure the deficiency, potentially through a reverse stock split. The company will regain compliance if its stock's closing bid price reaches at least $1.00 for 10 consecutive business days within this period. Failure to demonstrate compliance by the deadline may lead to delisting, although SenesTech would have the right to appeal. The company's future ability to meet the Nasdaq's continued listing requirements remains uncertain.